Realty Income Earnings Preview: What Wall Street Is Watching - 24/7 Wall St.[S&P 5006,892.40 +0.65%] [Dow Jones49,242.00 +0.80%][Nasdaq 10024,988.60 +0.99%][Russell 20002,653.04 +0.94%][FTSE 10010,707.00 +0.22%][Nikkei 22558,070.30 +2.23%][Stock Market Live February 24, 2026: S&P 500 (SPY) Rebounding from Monday Disaster][Investing]# Realty Income Earnings Preview: What Wall Street Is Watching### Quick ReadRealty Income (O) raised full-year AFFO guidance to $4.25-$4.27 per share. The company must hit that r ...

Key Takeaways AMT posted Q4 AFFO of $2.63 per share, beating estimates and rising from $2.32 a year ago.American Tower's revenues rose 7.5%, with property revenues up 7.6% year over year.AMT expects 2026 AFFO per share of $10.78-$10.95 and property revenues up 2% at midpoint.American Tower Corporation (AMT) reported its fourth-quarter 2025 adjusted funds from operations (AFFO), attributable to AMT common stockholders, per share of $2.63, beating the Zacks Consensus Estimate of $2.54. This compared favorably ...

INNOVATIVE INDUSTRIAL PROPERTIES NYSE: IIPR INNOVATIVEINDUSTRIALPROPERTIES.COM COMPANY PRESENTATION – FEBRUARY 2026 1 Innovative Industrial Properties FORWARD LOOKING STATEMENTS This presentation and our associated comments includes "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that are subject to risks and uncertainties. In pa ...

DHC said SHOP results were driven by improving occupancy, pricing, and margins. Same-property SHOP occupancy increased 90 basis points year-over-year to 82.4%, while the average monthly rate increased 5.8%. Same-property SHOP NOI margins improved by 230 basis points year-over-year, with management pointing to revenue growth as a key factor.Medical office and life science NOI of $108.1 million, slightly above the midpoint of guidanceManagement said full-year consolidated NOI grew 31.3% in 2025, supported by ...

Financial Data and Key Metrics Changes - In 2025, the company achieved consolidated NOI growth of 31.3% and reduced leverage by over three turns, with no debt maturities until 2028 [6][12] - Total revenue for the fourth quarter was $379.6 million, with Adjusted EBITDAre of $72.4 million and Normalized FFO of $21.8 million or $0.09 per share [8][22] - Full year Adjusted EBITDAre was $284 million, at the high end of guidance [22] Business Line Data and Key Metrics Changes - The SHOP NOI for the full year was $139.3 million, driven by a same-property occupancy increase of 90 basis points year-over-year to 82.4% and an average monthly rate increase of 5.8% [8][16] - Medical office and life science NOI was $108.1 million, just above the midpoint of guidance, while triple net lease senior living community and wellness center NOI was $31.1 million, exceeding guidance [22] Market Data and Key Metrics Changes - Consolidated occupancy in the medical office and life science portfolio increased by 460 basis points sequentially to 91.2% [11] - Same-property Cash Basis NOI increased 3.8% year-over-year, with margins improving 100 basis points to 59.6% [11] Company Strategy and Development Direction - The company aims to continue unlocking value through operational improvements and has identified approximately 15 locations for potential reopening of wings, which could add around 500 units to the portfolio [27] - Future dispositions will be opportunistic, focusing on reducing leverage or redeploying into accretive initiatives [14][46] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the 2026 outlook, supported by a robust demand for SHOP communities and a favorable industry outlook [10][14] - The company anticipates strong improvements in SHOP segment performance and reduced debt, driving free cash flow growth [22] Other Important Information - The company completed the wind down of AlerisLife, transitioning 116 communities to seven operators and completed renovations at over 30 communities [5][6] - The company expects recurring capital expenditures for 2026 to range from $100 million to $115 million, representing an over 18% decrease compared to 2025 [18] Q&A Session Summary Question: What is the go-forward strategy and opportunities for reopening wings? - The main strategy focuses on growing performance through operations, with potential for 500 units from reopening wings at identified locations [26][27] Question: Will external investments focus on renovations or acquisitions? - Renovations are prioritized for better risk-adjusted returns, but acquisitions are not ruled out for the future [28][29] Question: What drove the fourth quarter margin improvement? - The improvement was due to a combination of reduced transition disruptions and core operational gains [30] Question: What are the trends for January and February? - January showed promising results in line with expectations, with rent escalators around 4%-6% [32][33] Question: How does the company view NOI growth for the coming quarters? - NOI growth is expected to be back half of the year weighted due to ongoing transitions [38] Question: What are the prospects for renewing leases in the medical office and life science segment? - There are promising outlooks for re-leasing, particularly in the Fremont building, which is in a strong R&D market [44] Question: What implications does the momentum have on dividends? - The board will consider dividends, but there are no immediate priorities for addressing them [52]

Financial Data and Key Metrics Changes - In 2025, the company achieved consolidated NOI growth of 31.3% and reduced leverage by over three turns, with no debt maturities until 2028 [6][12] - For Q4 2025, total revenue was $379.6 million, Adjusted EBITDAre was $72.4 million, and Normalized FFO was $21.8 million or $0.09 per share [7][20] - Full year Adjusted EBITDAre was $284 million, at the high end of guidance [20] Business Line Data and Key Metrics Changes - SHOP NOI for Q4 improved 27.6% year-over-year to $38.3 million, with full year SHOP NOI at $139.3 million, towards the high end of guidance [6][7] - Medical office and life science NOI was $108.1 million, just above the midpoint of guidance [21] - Same-property Cash Basis NOI increased 15.4% year-over-year to $70.4 million in Q4 [15] Market Data and Key Metrics Changes - Same-property occupancy for SHOP increased 90 basis points year-over-year to 82.4%, with average monthly rates up 5.8% [7][15] - Consolidated occupancy in the medical office and life science portfolio increased 460 basis points sequentially to 91.2% [11] Company Strategy and Development Direction - The company aims to unlock value through operational performance and is focused on executing property-specific business plans [9][26] - There is a healthy pipeline of ROI projects expected to add approximately 500 SHOP units, with an unlevered mid-teens ROI [10][27] - Future dispositions will be opportunistic, with proceeds used to reduce leverage or redeploy into accretive initiatives [12][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 2026 outlook due to robust demand for SHOP communities and a favorable industry outlook [10][14] - The company anticipates continued increases in revenue and occupancy, leading to strong NOI and margin growth in 2026 [15][20] Other Important Information - The company completed the wind down of AlerisLife, transitioning 116 communities to seven operators [5] - G&A expenses for Q4 included a $5.7 million business management incentive fee, driven by a total shareholder return of nearly 113% in 2025 [16] Q&A Session Summary Question: What is the go-forward strategy and opportunities for reopening wings at existing communities? - The main strategy is to grow performance through operations, with potential to add close to 500 units through identified wings at a cost of $125-$175 per unit [26][27] Question: Will external investments focus on renovations or acquisitions? - Renovations are expected to provide better risk-adjusted returns, but acquisitions are not the current focus [28][29] Question: What drove the Q4 margin improvement? - The improvement was a combination of reduced transition noise and core operational gains [30][31] Question: What are the trends for January and February? - January showed promising results in line with expectations, with rent escalators around 4%-6% [33][34] Question: How should NOI growth be expected over the coming quarters? - NOI growth is expected to be back half of the year weighted due to occupancy growth and rate increases [38][40] Question: What are the prospects for renewing or releasing medical office and life science assets? - There are promising prospects for re-leasing, particularly for a building in Fremont, California [44] Question: What implications does the momentum have on the dividend? - The board will consider the dividend, but there are no immediate priorities for addressing it [51]

Retirees Should Know Why The High Yield Small Cap ETF XSHD Cut Payouts 28% - 24/7 Wall St.[S&P 5006,882.50 +0.51%][Dow Jones49,223.20 +0.76%][Nasdaq 10024,971.00 +0.92%][Russell 20002,658.72 +1.15%][FTSE 10010,713.00 +0.28%][Nikkei 22557,920.30 +1.97%][Stock Market Live February 24, 2026: S&P 500 (SPY) Rebounding from Monday Disaster][Investing]# Retirees Should Know Why The High Yield Small Cap ETF XSHD Cut Payouts 28%### Quick ReadInvesco's SmallCap High Dividend ETF (XSHD) cut distributions 28% by mid-20 ...

Core Insights - Analysts expect CubeSmart (CUBE) to report quarterly earnings of $0.66 per share, reflecting a year-over-year decline of 2.9% [1] - Revenue projections stand at $280.47 million, indicating a 21.2% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting analysts have reassessed their initial projections [1] Earnings Projections - Analysts forecast 'Property management fee income' to reach $10.16 million, showing a year-over-year decline of 2.2% [4] - 'Rental income' is estimated at $244.19 million, representing a 7% increase from the previous year [4] - 'Other property related income' is expected to be $30.87 million, indicating a year-over-year growth of 6.1% [4] Additional Metrics - The average prediction for 'Depreciation and amortization' is set at $67.16 million [5] - CubeSmart shares have increased by 5.3% over the past month, contrasting with a -1% change in the Zacks S&P 500 composite [5] - CubeSmart holds a Zacks Rank 4 (Sell), suggesting it may underperform the overall market in the near term [5]

Core Viewpoint - Wall Street analysts anticipate EPR Properties to report quarterly earnings of $1.29 per share, reflecting a year-over-year increase of 5.7%, with revenues expected to reach $155.56 million, up 4.3% from the previous year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 0.1%, indicating a collective reassessment by analysts of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Revenue- Rental revenue' to be $155.45 million, representing a 4.3% increase from the year-ago quarter [5]. - The estimate for 'Revenue- Mortgage and other financing income' is $15.53 million, indicating a 4.1% increase from the previous year [5]. - 'Revenue- Other income' is expected to be $10.10 million, which reflects a significant decrease of 23.5% from the year-ago quarter [5]. Other Key Metrics - 'Depreciation and amortization' is predicted to reach $41.00 million [6]. - EPR Properties shares have increased by 12.1% over the past month, contrasting with a -1% change in the Zacks S&P 500 composite [6]. - EPR Properties holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6].

Financial Results and Supplemental Information FOURTH QUARTER 2025 February 23, 2026 Diversified Healthcare Trust Announces Fourth Quarter 2025 Financial Results "DHC finished an active 2025 on a strong note and is carrying significant positive momentum into 2026. Fourth quarter and full year results came in at the high end of our expectations, with fourth quarter same property SHOP NOI improving 27.6% over last year to $38.3 million, and full year SHOP NOI improving 31.3% to $139.3 million. Same property S ...